DJIA 17,959.37 154.57 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

ATHERSYS, INC. (NASDAQ: ATHX)



company name or ticker

Athersys Management Discusses Q2 2013 Results - Earnings Call Transcript

Trade the Earnings: Athersys, Inc.

5 Biotech Stocks Under $10 Making Big Moves

Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease

NeoStem Inc: A Stem Cell Company With an Attractive Valuation

NeoStem is able to combine a therapeutic development business with a revenue-generating service provider business.

Wider-Than-Expected Loss at Athersys - Analyst Blog

Athersys Management Discusses Q1 2013 Results - Earnings Call Transcript

Elan in Royalty Deal with THRX - Analyst Blog

After-Hours Earnings Report for May 14, 2013 : A, EXP, VIPS, PLAB, VOXX, ATHX, FENG, ALXA, TKMR, PR

After-Hours Earnings Report for May 14, 2013 : A, EXP, VIPS, PLAB, VOXX, ATHX, FENG, ALXA, TKMR, PRMW, QBAK, TXCC

Celgene Attains 52-Week High - Analyst Blog